share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-10% Owner CR Group L.P.

SEC announcement ·  May 13 18:24
Summary by Moomoo AI
CR Group L.P., a significant shareholder in T2 Biosystems, Inc. [TTOO], reported acquiring a total of 1,823,800 shares of common stock on May 9, 2024. The transactions were made indirectly through CRG Partners III - Parallel Fund B (Cayman) L.P. Following these acquisitions, CR Group L.P. now holds a total of 4,704,729 shares in the company. The shares were acquired with the transaction code 'C', indicating that these were not open market transactions. The total number of shares held by CR Group L.P. before these transactions was 9,300,706. The nature of the shares is indirect, and the specific transaction prices were not disclosed in the announcement.
CR Group L.P., a significant shareholder in T2 Biosystems, Inc. [TTOO], reported acquiring a total of 1,823,800 shares of common stock on May 9, 2024. The transactions were made indirectly through CRG Partners III - Parallel Fund B (Cayman) L.P. Following these acquisitions, CR Group L.P. now holds a total of 4,704,729 shares in the company. The shares were acquired with the transaction code 'C', indicating that these were not open market transactions. The total number of shares held by CR Group L.P. before these transactions was 9,300,706. The nature of the shares is indirect, and the specific transaction prices were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more